Research Article| Volume 19, ISSUE 1, P126-127, January 1997

The added value of newer antipsychotics

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Keks N
        • Sacks T
        Schizophrenia and the community.
        Med J Aust. 1996; 164: 583-584
        • Glazer WM
        The impact of managed care systems on relapse prevention and quality of life for patients with schizophrenia.
        Eur Neuropsychopharmacol. 1996; 6 (Suppl 2): S2 35-S2 39
        • Lehman A
        Quality of life issues and assessment among persons with schizophrenia.
        in: Moscarelli M Rupp A Sartorius N Handbook of Mental Health Economics and Health Policy. 1. Wiley, Chichester, UK1996 (Schizoprenia)